Edition:
United States

Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

707.40INR
5:21am EST
Change (% chg)

Rs4.10 (+0.58%)
Prev Close
Rs703.30
Open
Rs700.70
Day's High
Rs714.25
Day's Low
Rs700.70
Volume
943,233
Avg. Vol
2,213,723
52-wk High
Rs895.00
52-wk Low
Rs582.00

Latest Key Developments (Source: Significant Developments)

Aurobindo Pharma says co became aware of complaint from numerous states filed in Connecticut
Friday, 16 Dec 2016 02:46am EST 

Aurobindo Pharma Ltd : says co became aware of complaint from numerous states filed in Connecticut . says received subpoena in mar 2016 requesting non-product specific information . says have not received any further requests for information or subpoenas after March 2016 subpoena .says sales of Glyburide by our US subsidiary is not material.  Full Article

Aurobindo Pharma unit Arrow Generiques to buy select assets in France from Teva
Friday, 25 Nov 2016 07:21am EST 

Aurobindo Pharma Ltd : Aurobindo Pharma Ltd says Arrow Generiques to acquire select assets in France from Teva . Aurobindo Pharma Ltd says Arrow Generiques will integrate the products with existing commercial operations in France . Aurobindo Pharma Ltd says Arrow Generiques and Teva intend to ensure continuity of the supply of the products to the market. .Aurobindo Pharma - Arrow Generiques to buy right, title and interest in products calcium and calcium vitamin d3, including use of the orocal trademark..  Full Article

Aurobindo Pharma gets USFDA tentative approval for Dolutegravir
Thursday, 22 Sep 2016 03:12am EDT 

Aurobindo Pharma Ltd :Aurobindo Pharma receives USFDA tentative approval for Dolutegravir, allowing the product to be launched in the PEPFAR market.  Full Article

Aurobindo Pharma receives USFDA approval for Linezolid injection
Monday, 8 Aug 2016 12:33am EDT 

Aurobindo Pharma Ltd : Aurobindo Pharma receives USFDA approval for Linezolid injection . Product is expected to be launched by Q2 FY 2016-17 .  Full Article

Aurobindo Pharma gets USFDA approval for rosuvastatin calcium tablets
Wednesday, 20 Jul 2016 12:19am EDT 

Aurobindo Pharma Ltd : Aurobindo Pharma receives usfda approval for rosuvastatin calcium tablets .  Full Article

Aurobindo Pharma gets USFDA approval for hydromorphone hydrochloride tablets
Tuesday, 17 May 2016 01:50am EDT 

Aurobindo Pharma Ltd : Aurobindo Pharma receives usfda approval for hydromorphone hydrochloride tablets .  Full Article

Aurobindo Pharma gets US FDA approval for bupivacaine hydrochloride injection
Monday, 16 May 2016 12:20am EDT 

Aurobindo Pharma Ltd : Gets US FDA approval for bupivacaine hydrochloride injection .  Full Article

Aurobindo Pharma gets USFDA approval for Zolmitriptan tablets
Friday, 13 May 2016 05:03am EDT 

Aurobindo Pharma Ltd : Receives USFDA approval for Zolmitriptan tablets; product expected to be launched in Q2 FY 2016-17 .  Full Article

Aurobindo Pharma gets USFDA approval for Fenofibrate tablets
Friday, 6 May 2016 01:28am EDT 

Aurobindo Pharma Ltd : Aurobindo Pharma receives USFDA approval for Fenofibrate tablets; product is expected to be launched in Q1 FY 2016-17 .  Full Article

Aurobindo Pharma Ltd receives USFDA Approval for Dexmedetomidine Hydrochloride Injection
Friday, 18 Mar 2016 01:10am EDT 

Aurobindo Pharma Ltd:Says that it has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Dexmedetomidine Hydrochloride Injection, 200 mcg (base)/2 mL (100 mcg (base)/mL) single-dose vials.  Full Article

India's Aurobindo shares hit nine-month low on US price-fixing lawsuit

MUMBAI Indian drugmaker Aurobindo Pharma Ltd's shares hit their lowest in more than nine months on Friday after the company was named in a lawsuit alleging it colluded with other drugmakers to fix prices of two commonly used drugs in the United States.